SENSUS HEALTHCARE INC (SRTS) Forecast, Price Target & Analyst Ratings

NASDAQ:SRTS • US81728J1097

Current stock price

3.92 USD
-0.09 (-2.24%)
At close:
3.87 USD
-0.05 (-1.28%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SENSUS HEALTHCARE INC (SRTS).

Forecast Snapshot

Consensus Price Target

Price Target
$6.80
+ 73.47% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.13
Revenue Estimate
5.43M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.80
Upside
+ 73.47%
From current price of $3.92 to mean target of $6.80, Based on 9 analyst forecasts
Low
$6.06
Median
$6.12
High
$8.40

Price Target Revisions

1 Month
-9.09%
3 Months
-9.09%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for SRTS. The average price target is 6.8 USD. This implies a price increase of 73.47% is expected in the next year compared to the current price of 3.92.
The average price target has been revised downward by 9.09% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SRTS Current Analyst RatingSRTS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

SRTS Historical Analyst RatingsSRTS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
SRTS was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about SRTS.
In the previous month the buy percentage consensus was at a similar level.
SRTS was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-17Maxim GroupMaintains Buy -> Buy
2025-08-12HC Wainwright & Co.Maintains Buy -> Buy
2025-08-08Lake StreetMaintains Buy -> Buy
2025-05-19Maxim GroupMaintains Buy -> Buy
2025-04-04HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-11Lake StreetMaintains Buy -> Buy
2025-02-10HC Wainwright & Co.Maintains Buy -> Buy
2024-11-18HC Wainwright & Co.Maintains Buy -> Buy
2024-11-15Maxim GroupMaintains Buy -> Buy
2024-08-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-13HC Wainwright & Co.Maintains Buy -> Buy
2024-05-10Maxim GroupMaintains Buy -> Buy
2023-11-13HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-07HC Wainwright & Co.Maintains Buy -> Buy
2023-05-04Alliance Global PartnersMaintains Buy
2023-05-04HC Wainwright & Co.Reiterate Buy
2023-02-10Alliance Global PartnersMaintains Buy
2023-02-10HC Wainwright & Co.Reiterate Buy
2022-11-04Alliance Global PartnersMaintains Buy
2022-05-06HC Wainwright & Co.Maintains Buy
2022-03-03HC Wainwright & Co.Maintains Buy
2022-02-14HC Wainwright & Co.Maintains Buy
2021-12-02HC Wainwright & Co.Maintains Buy
2021-11-05HC Wainwright & Co.Maintains Buy
2021-08-06HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.13
Revenue Estimate
5.43M
Revenue Q2Q
-34.92%
EPS Q2Q
20.31%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
-23.56%
Revenue (3 Months)
-35.33%
EPS (1 Month)
-50.01%
EPS (3 Months)
-150.00%

Next Earnings Summary

SRTS is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.13 USD and the consensus revenue estimate is 5.43M USD.
The next earnings revenue estimate has been revised downward by 35.33% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
SRTS revenue by date.SRTS revenue by date.
24.405M
-45.19%		41.807M
71.31%		27.482M
-34.26%		28.032M
2.00%		37.627M
34.23%		44.512M
18.30%		80.05M
79.84%		92.057M
15.00%
EBITDA
YoY % growth
SRTS ebitda by date.SRTS ebitda by date.
-107K
-100.71%		8.329M
7,884.11%		-9.921M
-219.11%		-8.772M
11.58%		-1.326M
84.88%		1.122M
184.62%		-12.146M
-1,182.55%		-21.921M
-80.48%
EBIT
YoY % growth
SRTS ebit by date.SRTS ebit by date.
-382K
-102.58%		8.09M
2,217.80%		-10.307M
-227.40%		-5.902M
42.74%		13.77K
100.23%		1.728M
12,449.02%		14.36M
731.02%		16.514M
15.00%
Operating Margin
SRTS operating margin by date.SRTS operating margin by date.
-1.57%19.35%-37.50%-21.05%0.04%3.88%17.94%17.94%
EPS
YoY % growth
SRTS eps by date.SRTS eps by date.
0.03
-95.59%		0.40
1,233.33%		-0.47
-217.50%		-0.29
38.51%		0.10
133.53%		0.03
-68.42%		0.69
2,166.67%		0.80
14.71%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.13
20.31%		-0.09
-47.34%		-0.02
71.66%		0.07
137.58%
Revenue
Q2Q % growth		5.43M
-34.92%		6.497M
-11.18%		10.45M
51.80%		13.135M
165.94%
EBITDA
Q2Q % growth		-2.47M
3.52%		-2.448M
-39.25%		-612K
73.23%		3.06M
210.79%
EBIT
Q2Q % growth		-2.636M
0.37%		-1.906M
1.88%		-396.78K
84.56%		1.371M
143.55%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SRTS Yearly Revenue VS EstimatesSRTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M
SRTS Yearly EPS VS EstimatesSRTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
27.34%
EPS Next 5 Year
29.86%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
12.24%
Revenue Next 5 Year
23.94%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
28.62%
EBIT Next 5 Year
-20.08%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SENSUS HEALTHCARE INC / SRTS Forecast FAQ

What is the average price target for SENSUS HEALTHCARE INC (SRTS) stock?

9 analysts have analysed SRTS and the average price target is 6.8 USD. This implies a price increase of 73.47% is expected in the next year compared to the current price of 3.92.

When does SENSUS HEALTHCARE INC (SRTS) report earnings?

SENSUS HEALTHCARE INC (SRTS) will report earnings on 2026-05-13, after the market close.

What are the consensus estimates for SRTS stock next earnings?

The consensus EPS estimate for the next earnings of SENSUS HEALTHCARE INC (SRTS) is -0.13 USD and the consensus revenue estimate is 5.43M USD.

What is the expected long term growth rate for SENSUS HEALTHCARE INC (SRTS)?

The expected long term growth rate for SENSUS HEALTHCARE INC (SRTS) is 12.24%.